Related Experiment Video
Updated: Jun 14, 2025
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
Surgical and Perioperative Advances for Patients With Locally Advanced Non-Small Cell Lung Cancer
Anne Opalikhin1, Scott Friedland2, Maria Lucia Madariaga1
1Department of Surgery, The University of Chicago, Chicago, IL.
Summary
Recent advancements in treating locally advanced non-small cell lung cancer (NSCLC) offer more effective options. Tailored therapies and surgical innovations improve outcomes and increase cure rates for patients with resectable NSCLC.
Area of Science:
- Oncology
- Thoracic Surgery
- Pulmonary Medicine
Background:
- Locally advanced non-small cell lung cancer (NSCLC) traditionally requires multimodality treatment.
- Evolving management strategies aim to enhance efficacy and tolerability for resectable NSCLC.
- Preventing recurrence and improving cure rates are key objectives in NSCLC treatment.
Purpose of the Study:
- To outline recent developments in the treatment of locally advanced NSCLC.
- To highlight the impact of neoadjuvant, perioperative, and adjuvant therapies.
- To discuss innovations in surgical techniques and precision medicine for NSCLC.
Main Methods:
- Review of advancements in multimodality therapy for NSCLC.
- Analysis of innovations in surgical techniques and perioperative care.
- Focus on the role of tailored systemic therapies in the perioperative setting.
Main Results:
- Significant progress in surgical techniques and perioperative care.
- Increased patient eligibility for curative-intent surgery.
- Improved patient outcomes with reduced morbidity and mortality.
Conclusions:
- Multimodality therapy for locally advanced NSCLC has seen substantial advancements.
- Precision medicine and tailored perioperative treatments are crucial for improving outcomes.
- Innovations are expanding surgical options and enhancing cure rates for resectable NSCLC.
